TAPIR Trial Recruiting Patients Who Take Rituximab

The Assessment of Prednisone in Remission (TAPIR) Trial has recently expanded its eligibility criteria to enroll patients that have recently taken or are currently taking Rituximab. What we are studying: The TAPIR trial is a clinical trial for patients who have granulomatosis with polyangiitis (GPA, also known as Wegener’s granulomatosis)…...

Read more

How to Balance School and Vasculitis: Perspectives from Students and Parents

Lori Larson and son, Matt Larson by Ed Becker Being a young adult with vasculitis is challenging enough, but trying to navigate through school while managing the illness demands extraordinary skills. We asked a cross-section of young adult patients (and some parents) how they found the balance between health and…...

Read more

Pathway to Diagnosis (P2D) Plans an Innovative Study with the Goal of Reducing Delays in Diagnosis

P2D Objective Using big data to accurately predict a diagnosis using predictive analytics and machine learning methods. The Reality: Delays in diagnosis for patients with vasculitis Despite remarkable medical advances, diagnostic delays for patients with vasculitis remain extremely common and are a major cause of increased morbidity and mortality. This…...

Read more

Ohio State University Opens Multidisciplinary Vasculitis Clinic

by John Fries The Ohio State University Wexner Medical Center, a large academic medical center on the campus of The Ohio State University in Columbus, Ohio, has established an on-site Multidisciplinary Vasculitis Clinic to provide enhanced care for patients with vasculitis. The Clinic, which opened in December 2017 and is…...

Read more

2018 Kansas University Vasculitis Conference Includes Programs on Vasculitis Diagnosis, Medications and Research

by Suzanne DePaolis, Member, VF Board of Directors More than 60 participants attended the August 4, 2018, VF Vasculitis Educational Conference. On August 4, I had the pleasure of attending and speaking at the Kansas University – VF Vasculitis Educational Conference. I am an education junkie, so I love attending…...

Read more